Skip to main content
Clinical Trials/NL-OMON49616
NL-OMON49616
Completed
Not Applicable

B cell signalling differences in acute cellular rejection after lung transplantation (HAMLET) - Hamlet

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • 1\. Patients (18\-70 years) who underwent uni\- or bilateral lung transplantation.
  • 2\. Written informed consent.
  • 3\. One or more episodes of acute cellular rejection within the first two years
  • after lung transplantation
  • 4\. No episode of acute cellular rejection within the first two years after lung
  • transplantation.

Exclusion Criteria

  • 1\. Non\-compliance to treatment
  • 2\. Active or treated malignancy (solid or hematological malignancies).
  • 3\. Who underwent a lung retransplantation.
  • 4\. Repetitive episodes of infection in advance of an episode of acute cellular

Outcomes

Primary Outcomes

Not specified

Similar Trials